Health-Kit Enabled Mobile App for Tobacco Cessation
FHIR-ed Up for Tobacco Cessation: Health-Kit Enabled Mobile App for Tobacco Cessation
2 other identifiers
interventional
51
1 country
1
Brief Summary
Tobacco use is the leading preventable cause of death in the US, contributing to more than 480,000 premature deaths each year. The Tobacco Treatment Guidelines underscore the need to offer patients who use tobacco products brief interventions that include prescriptions for proven pharmacological smoking cessation aids and proactive connections to evidence-based behavioral support. The rapid expansion of smart phone capabilities enhances the potential for tobacco cessation apps to personalize behavior change guidance and to send contextually relevant tailored behavior change nudges based on readiness to quit and electronic heath record (EHR) data. Rich data from EHRs are now available to third-party apps from the Health app (iOS) via Fast Healthcare Interoperability Resources standard Application Programming Interface (API). This Phase I Small Business Innovation Research (SBIR) explored the effects of one such innovative health IT solution. refresh is a highly individualized tobacco cessation HealthKit enabled app that 1) implemented a full range of best practices in tailored health behavior change communications based on readiness to change; 2) provided individualized behavior change guidance based on Health app data; and 3) concisely provided data and documentation of key actionable insights in the EHR on the patient's smoking status, app usage, and brief micro-message delivered by clinicians to reinforce and accelerate a patient's behavior change progress. This interoperability provided value to both patients and clinicians; empowered and supported successful and lasting behavior change; and enabled the implementation and evaluation of a best-in-class approach to tobacco and nicotine treatment. Extensive end user and stakeholder input ensured that refresh was designed for rapid dissemination. Patients of an integrated delivery system with an upcoming appointment (n=51) were recruited to participate in a 30-day pilot test. Pre-post comparisons of Patient-Reported Outcomes Measurement Information System (PROMIS) measure for tobacco (psychosocial expectancies) and confidence for quitting provided preliminary data on the effects of the program. The hypothesis was that the patients who utilize refresh will have significantly higher psychosocial expectancies regarding tobacco at follow-up and greater confidence to quit smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2022
CompletedStudy Start
First participant enrolled
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 21, 2023
CompletedFirst Posted
Study publicly available on registry
March 4, 2024
CompletedResults Posted
Study results publicly available
February 13, 2025
CompletedMay 16, 2025
May 1, 2025
1.5 years
February 28, 2022
November 22, 2024
May 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychosocial Expectancies (PROMIS Smoking Initiative) Patient Reported Outcome
This reliable and valid 6-item assessment measures feelings of social disapproval of smoking, normative values associated with smoking, and negative beliefs about appearance when smoking (e.g., If I quit smoking I will be more in control of my life). It will be the primary outcome as it is appropriate for all smokers (ready to quit or not) and is highly correlated with interest in quitting (r=0.59). It is also correlated with recency of quit attempts. Participants respond on a 5-point Likert Scale from 0 (Not at all) to 4 (Very much). Raw scores range from a minimum of 0 to a maximum of 24, with higher scores indicating better outcomes. The reliability of the scale is 0.85.
Pretest (baseline) and Posttest (30 day follow-up)
Secondary Outcomes (1)
Confidence
Pretest (baseline) and Posttest (30 day follow-up)
Study Arms (1)
App users
EXPERIMENTALAll participants will be provided with access to the intervention app (refresh).
Interventions
A theoretically-grounded, highly individualized tobacco cessation Health-Kit enabled app. Unlike existing tobacco cessation apps, refresh: 1) implements a full range of best practices in tailored health behavior change communications; 2) individualizes messaging based on the patient's clinical context using Health app data obtained through Fast Healthcare Interoperability Resources (FHIR) standard Application Programming Interfaces (API) and behavior change constructs; and 3) provides data and key insights back to the EHR.
Eligibility Criteria
You may qualify if:
- Age 18 or older
- Current cigarette smoker
- Having an iPhone 6s or higher
- Willing and able to download a mobile app
- Able to read and speak English
- Having an upcoming appointment with a participating clinician in the next 42 days
You may not qualify if:
- Younger than 18
- Non-smoker
- Unable to read and speak English
- Not having an iPhone 6s or higher
- Not having an appointment with a participating clinician in the next 42 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pro-Change Behavior Systems, Inc
South Kingstown, Rhode Island, 02879, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sara Johnson, PhD
- Organization
- Pro-Change Behavior Systems, Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Johnson, Ph.D.
Pro-Change Behavior Systems, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-President & CEO
Study Record Dates
First Submitted
February 28, 2022
First Posted
March 4, 2024
Study Start
March 21, 2022
Primary Completion
September 21, 2023
Study Completion
September 21, 2023
Last Updated
May 16, 2025
Results First Posted
February 13, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
A variety of peer-reviewed publications will emerge from the proposed research. At the conclusion of the study, the data will be de-identified and then made available to those requesting access, provided that they sign an agreement that the data will be used for research purposes only. Pro-Change routinely asks those requesting access to any data to sign such a form.